Modified vaccinia virus Ankara as a vector for suicide gene therapy. - Wikidata - thesis-toulmin - TriplyDB

Modified vaccinia virus Ankara as a vector for suicide gene therapy.

Modified vaccinia virus Ankara as a vector for suicide gene therapy.

http://www.wikidata.org/entity/Q40054213

about

Progresses towards safe and efficient gene therapy vectors The evolution of poxvirus vaccines Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus.Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection A selectable and excisable marker system for the rapid creation of recombinant poxviruses.Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion.Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment.A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma Clinical development of MVA-based therapeutic cancer vaccines.Oncolytic vaccinia virus for the treatment of cancer.Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes.Cell engineering and molecular pharming for biopharmaceuticals.Cowpox Virus: A New and Armed Oncolytic Poxvirus.The immunogenicity of the tumor-associated antigen α-fetoprotein is enhanced by a fusion with a transmembrane domain.Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency

P2860

Q26781432-D275207D-E6C9-41F6-A16F-FC1AC399C550 Q26995905-0CF03B43-DE3B-402C-8A1E-797ADB2C77FD Q30369123-919BCBC5-5EF8-40D5-A5B9-B8C63EA1049C Q33370547-B03EF9AC-F63E-4224-A525-B9B5A053BF95 Q34023827-E41F8431-09C4-4FCA-BAB1-6F0BE868F99C Q34137180-F56A13D3-8E04-49D8-A6C9-2F30794C7F55 Q35677112-DFC58DC8-782F-4F05-A35A-55558B5FB71A Q36711042-A99D4263-7074-4ABB-9657-689D0A954F5B Q36848730-1FB7CA45-8032-40D2-813C-169C190F837F Q37259579-915CA3B5-1E41-4DBE-8F9A-10DD717C0E51 Q37845399-3CDDF1BB-FB3A-402F-8421-32C95049D4FD Q38673968-014DF82D-9DA2-4D4D-9B15-1B6792DBEC7B Q38790788-EA649AF6-7765-457B-9CD2-FD50587C3A0E Q40139717-B11F3BC9-8469-4589-9F30-B6A4C36F8A95 Q41689720-C2157F20-FFC0-460F-9BF3-C29A3B462F20 Q41876459-E535C84F-1F48-4AD0-AEF7-0ABD0BE64A04 Q43493342-1F9DEACD-FC1A-455B-880D-1410558377D8 Q56889716-F6554CCC-1A6F-4521-8EFF-D44C9DB23CEF

P2860

Modified vaccinia virus Ankara as a vector for suicide gene therapy.

http://www.wikidata.org/entity/Q40054213

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Modified vaccinia virus Ankara as a vector for suicide gene therapy.

@en

type

label

Modified vaccinia virus Ankara as a vector for suicide gene therapy.

@en

prefLabel

Modified vaccinia virus Ankara as a vector for suicide gene therapy.

@en

P1433

Q40054213-81AEB6DE-A261-42DE-9490-DC2ED41B5446

P1476

Q40054213-33EDAD5A-603A-4554-A0A1-F248E820D36D

P2093

Q40054213-2256BB60-4A01-40BE-A144-98BD108CC516

Q40054213-399DC0E2-F56F-4A63-8E2D-9E9326EC7F22

Q40054213-692958C9-0F38-4D9D-9758-CC9901D84ECC

Q40054213-7D049802-0D41-47FC-968C-A1FA63138836

Q40054213-8678F4CF-B2DC-4BA7-B763-C5F81D7CBB18

Q40054213-8ADDFF80-7BCC-4CB3-B5A4-74F58211B0D2

Q40054213-C71775EF-76DF-440D-BA66-5DD0919816CD

P2860

Q40054213-03785B61-9C82-446A-9DE6-F50C589BEF09

Q40054213-0539F266-FE6B-4734-B203-0A242CACD9C2

Q40054213-0AC542EC-96B7-431E-9444-DDED6D20AEC3

Q40054213-0D2E4E45-52A4-41F6-B820-083708CF6760

Q40054213-0E5A1C9C-D1B2-4C24-9E86-3CD8E85E6C0C

Q40054213-121B9122-6904-4C51-8BFC-A83933CAF505

Q40054213-12266E8F-984D-4C3F-9CCD-318E90F7F4BC

Q40054213-223B2723-B984-4495-AE7E-A9133C366714

Q40054213-366F4526-12BB-443A-83C4-5FE0332D6164

Q40054213-3B84819F-55CB-4858-A850-6F8812A2E0F4

P2888

Q40054213-FE9EB1D7-75EB-4803-BAA6-D0360A5A0385

P304

Q40054213-74C1B244-A700-493C-BC79-7E4C218BCA23

P31

Q40054213-D278D1B7-DA0E-4531-B830-CC4221BCE1AF

P356

Q40054213-D543104A-8846-4EB3-89A2-836FC7965762

P433

Q40054213-DBB8305C-1466-4955-BCB3-CBCFC7363807

P478

Q40054213-011191C8-45B4-42D5-9819-570361A5A1D7

P577

Q40054213-239578BD-9E4A-47DE-B57C-7AA9FC0109C6

P5875

Q40054213-3C38D6E8-3A3C-4CCE-8F36-3FC6D0377549

P6179

Q40054213-C02649AE-6449-42A1-83B6-FC961082E8D0

P698

Q40054213-BE545623-0568-483A-9E16-78DAF9CF87E7

P921

Q40054213-0A80F7CF-02CA-4EB6-A5AB-F196266BCC27

Q40054213-9F818EEB-0C63-468A-83C0-C4FD1DCA41FD

Q40054213-C7C2320C-40A2-4BCF-A37F-1E4227CC5F7E

Q40054213-DD1C908B-D603-4670-8798-9BCB58284941

P356

P1433

Cancer Gene Therapy

P1476

Modified vaccinia virus Ankara as a vector for suicide gene therapy.

@en

P2093

Balloul JM

http://www.w3.org/2001/XMLSchema#string

Cordier P

http://www.w3.org/2001/XMLSchema#string

Erbs P

http://www.w3.org/2001/XMLSchema#string

Findeli A

http://www.w3.org/2001/XMLSchema#string

Geist M

http://www.w3.org/2001/XMLSchema#string

Hoffmann C

http://www.w3.org/2001/XMLSchema#string

Kintz J

http://www.w3.org/2001/XMLSchema#string

P2860

Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins

The FUR1 gene of Saccharomyces cerevisiae: cloning, structure and expression of wild-type and mutant alleles.

Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans.

The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.

The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminase.

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery.

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.

Nonreplicating vaccinia vector efficiently expresses recombinant genes.

Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits

P2888

P304

18-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.CGT.7701098

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5854972

http://www.w3.org/2001/XMLSchema#string

P6179

1017938162

http://www.w3.org/2001/XMLSchema#string

P698

17992203

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

veteran suicide